Insulin Lispro Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Insulin Lispro Injection (injection) from Eli Lilly and Co. with status To Be Discontinued. The shortage was first posted on 10/24/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Eli Lilly and Co.
- Package NDC
- 0002-8213-05
- Dosage Form
- Injection
- Presentation
- Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05)
- Initial Posting
- 10/24/2025
- Revised Date